Signaturefd, LLC Zai Lab LTD Transaction History

Signaturefd, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$27.77 - $64.4 $68,008 - $157,715	-2,449 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$54.9 - $105.21 $95,086 - $182,223	1,732 Added 241.56%	2,449 $154,000
Q3 2021 Oct 28, 2021	SELL	$105.0 - $178.37 $8,610 - $14,626	-82 Reduced 10.26%	717 $76,000
Q2 2021 Jul 26, 2021	BUY	$125.11 - $180.0 $15,388 - $22,140	123 Added 18.2%	799 $141,000
Q1 2021 Apr 30, 2021	BUY	$126.27 - $191.71 $38,512 - $58,471	305 Added 82.21%	676 $90,000
Q4 2020 Feb 11, 2021	BUY	$81.94 - $135.34 $13,274 - $21,925	162 Added 77.51%	371 $50,000
Q3 2020 Nov 03, 2020	BUY	$73.3 - $89.48 $11,654 - $14,227	159 Added 318.0%	209 $17,000
Q2 2020 Jul 30, 2020	BUY	$48.82 - $82.53 $1,513 - $2,558	31 Added 163.16%	50 $4,000
Q1 2020 Apr 23, 2020	BUY	$39.1 - $62.9 $742 - $1,195	19 New	19 $1,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.